Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Normal. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Normal at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate atopic dermatitis.
Sponsor: Incyte Corporation
Check if you qualify for this atopic dermatitis clinical trial in Normal, IL
If you're searching for atopic dermatitis treatment options in Normal, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Normal research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.